| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |